Keeler launches state-of-the-art manufacturing facility in China, driving localised production of ophthalmic equipment in Shanghai

We're happy to announce that we've recently launched a new manufacturing facility in hashtag#Shanghai, to better serve our Asian market.

20 February, 2025, Shanghai, China – Keeler, a global leader in the design and manufacture of ophthalmic medical devices, has announced that its world-class binocular indirect ophthalmoscope and slit lamps are now built locally in Shanghai. Whilst Keeler continues to manufacture its extended range of instruments within the UK, Chinese distribution partners and clinicians can now benefit from Keeler’s global expertise closer to home, with full manufacture of its flagship BIO, the Vantage Plus, as well as its KSL-H slit lamp range.

The launch of this new facility marks a major milestone in the expansion of Keeler’s global footprint, allowing the company to better serve growing demand for high-quality ophthalmic devices in China and the surrounding regions. Additionally, it supports the company’s sustainability efforts, resulting in a significant reduction in supply chain and transportation activities. By producing locally, Keeler can improve production efficiency and market responsiveness, reduce logistic costs, enhance the competitiveness of its products and better respond to customer needs.

As part of the localisation project, the dedicated Shanghai team successfully obtained Medical Device Registration certificates and a Medical Device Production License. These certifications demonstrate that Keeler’s products meet China’s rigorous medical device standards, showcasing the company’s ability to produce ophthalmic devices of the highest quality.

Keeler’s new facility includes advanced production equipment and strict production processes to ensure that every piece of equipment meets the highest quality standards. The factory’s layout and environmental conditions ensure safety and efficacy at every step of production. Coupled with a robust quality management system, the facility ensures that every aspect – from raw material procurement to finished product delivery – undergoes strict quality inspection to ensure safety and effectiveness.

Looking ahead, Keeler plans to expand its local production efforts to incorporate new product ranges and the company is actively seeking strategic partnerships with domestic and international companies to foster innovation, drive product development, and support Keeler’s continued international expansion.

Keeler China Operations Manager, Emma Wang said, “We’re delighted to launch our much-anticipated facility in China. It’s a testament to the hard work, dedication, and collaboration that has gone into making this vision a reality. This facility will enable us to provide more efficient, cost-effective solutions while maintaining the exceptional quality standards that Keeler is known for globally. We’re incredibly proud to be part of this important chapter in Keeler’s history, creating local opportunities, improving access to advanced ophthalmic care, and contributing to the growth of the medical device industry in China”.

Keeler’s Chief Operations Officer, Leon Forrest said, “The opening of our new manufacturing facility represents a pivotal moment for Keeler as we continue to deepen our commitment to the Chinese market. This expansion strengthens our position as a trusted partner to distributors and enhances our ability to meet their needs. We’re excited about the future and the opportunities this facility brings for both Keeler and our customers in the region.”